
Cellyan Biotechnology rose 37.3% from $1.18 to $1.62, ahead of the S&P 500's +13.3%. Its worst day was Sep 1 (−45.5%), and its low came Oct 22 at $0.10.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.01 was reported on $7.1M revenue.
−6.1% · S&P 500 −0.5%
EPS of $-0.07 was reported on $13.4M revenue.
−0.1% · S&P 500 0.0%
Story events cover the past 12 months · Times ET
Cellyan Biotechnology closed at its lowest level of the year, 91.9% below where the year started.
−5.9% · S&P 500 −1.2%
Where it ended: a close of $1.62 on Nov 13, 2026. Up next: H1 2027 earnings on Feb 23, 2027.
Nothing in the past 12 months.
All HKPD analyst actionsNothing in the past 12 months.
All HKPD dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for HKPD and SPY from Benzinga historical bars. Not investment advice.